Your browser doesn't support javascript.
loading
Preoperative predictors of nonorgan-confined disease in upper-tract urothelial carcinoma differ between China and the United States.
Singla, Nirmish; Fang, Dong; Su, Xiaohong; Bao, Zhengqing; Cao, Zhenpeng; Robyak, Haley; Xiong, Gengyan; Zhang, Lei; Woldu, Solomon; Hutchinson, Ryan; Sagalowsky, Arthur; Lotan, Yair; Li, Xuesong; Zhou, Liqun; Raman, Jay D; Margulis, Vitaly.
Afiliación
  • Singla N; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX.
  • Fang D; Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
  • Su X; Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
  • Bao Z; Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
  • Cao Z; Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
  • Robyak H; Division of Urology, Penn State Health Milton S. Hershey Medical Center, Hershey, PA.
  • Xiong G; Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
  • Zhang L; Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
  • Woldu S; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX.
  • Hutchinson R; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX.
  • Sagalowsky A; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX.
  • Lotan Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX.
  • Li X; Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
  • Zhou L; Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
  • Raman JD; Division of Urology, Penn State Health Milton S. Hershey Medical Center, Hershey, PA.
  • Margulis V; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address: vitaly.margulis@utsouthwestern.edu.
Urol Oncol ; 36(3): 88.e11-88.e18, 2018 03.
Article en En | MEDLINE | ID: mdl-29174945
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Transicionales / Neoplasias Urológicas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte / Asia Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Transicionales / Neoplasias Urológicas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte / Asia Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2018 Tipo del documento: Article